ARIX BIOSCIENCE PLC
Arix Bioscience PLC (ARIX)
Notice of Results
11-Feb-2021 / 07:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
=----------------------------------------------------------------------------------------------------------------------
Arix Bioscience plc
Notice of Results
LONDON, 11 February 2021: Arix Bioscience plc ("Arix", LSE: ARIX), a global venture capital company focused on
investing in and building breakthrough biotech companies, will announce its annual results for the year ended 31
December 2020, on Tuesday 9th March 2021.
Arix will host a virtual analyst presentation on the same day, at 12:00pm GMT, followed by a Q&A session, accessible
via conference call or webcast. The webcast of the presentation will be available on the Company's investor relations
website at https://arixbioscience.com/investor-relations/events-presentations.
For details of the conference call please contact optimum.arix@optimumcomms.com.
[ENDS]
Enquiries
For more information on Arix, please contact:
Arix Bioscience plc
Charlotte Parry, Head of Investor Relations
+44 (0)20 7290 1072
charlotte@arixbioscience.com
Optimum Strategic Communications
Supriya Mathur, Shabnam Bashir
+44 (0)20 3922 1906
optimum.arix@optimumcomms.com
About Arix Bioscience plc
Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech
companies around cutting-edge advances in life sciences.
We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate
their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth
phase of our industry to a broader range of investors. www.arixbioscience.com
=----------------------------------------------------------------------------------------------------------------------
ISIN: GB00BD045071
Category Code: NOR
TIDM: ARIX
LEI Code: 213800OVT3AHQCXNIX43
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.: 93411
EQS News ID: 1167627
End of Announcement EQS News Service
=------------------------------------------------------------------------------------
(END) Dow Jones Newswires
February 11, 2021 02:00 ET (07:00 GMT)
